BMS’ Opdivo gets expanded FDA and EU approval for Hodgkin lymphoma
This type of cancer is the most common one diagnosed in teenagers
Read More
Section: Regulatory
AstraZeneca’s Imfinzi approved in EU for early gastric and gastro-oesophageal cancers
This is the first and only perioperative immunotherapy approved to treat early gastric cancers
Read More
MHRA approves Leqselvi for severe alopecia areata
Around 30% of patients saw 80% more scalp hair after 24 weeks of treatment
Read More
Bristol Myers Squibb’s Sotyktu approved by US FDA for psoriatic arthritis
Sotyktu is the first TYK2 inhibitor approved for active psoriatic arthritis
Read More
Johnson & Johnson’s multiple myeloma treatment approved by US FDA
The approval was based on phase 3 data showing survival rates of 83.3% after three years
Read More